-+ 0.00%
-+ 0.00%
-+ 0.00%

DOGWOOD THERAPEUTICS INC: CO & PARTNER SERPIN PHARMA ANTICIPATE PATIENT ENROLLMENT IN SP16 PHASE 1B TRIAL TO BEGIN IN MIDDLE OF 2026

Reuters·04/15/2026 13:00:00

Please log in to view news